Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanuja Bordia

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
The European Journal of Neuroscience|June 21, 2018
Cholinergic control of striatal neurons to modulate L-dopa-induced dyskinesiasTanuja Bordia, Xiomara A Perez
Frontiers in Systems Neuroscience|December 28, 2020
The Inferior Colliculus in Alcoholism and BeyondTanuja Bordia, Natalie M Zahr
Biochemical Pharmacology|July 17, 2007
Nicotinic receptors as CNS targets for Parkinson's diseaseMaryka Quik, Tanuja Bordia, Kathryn O'Leary
Journal of Neurochemistry|February 5, 2013
The nicotine-mediated decline in l-dopa-induced dyskinesias is associated with a decrease in striatal dopamine releaseTanuja Bordia, J Michael McIntosh, Maryka Quik
The Journal of Pharmacology and Experimental Therapeutics|December 7, 2011
Nicotine reduces antipsychotic-induced orofacial dyskinesia in ratsTanuja Bordia, J Michael McIntosh, Maryka Quik
Movement Disorders : Official Journal of the Movement Disorder Society|June 14, 2012
Nicotine as a potential neuroprotective agent for Parkinson's diseaseMaryka Quik, Xiomara A Perez, Tanuja Bordia
The Journal of Pharmacology and Experimental Therapeutics|July 25, 2008
Continuous and intermittent nicotine treatment reduces L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesias in a rat model of Parkinson's diseaseTanuja Bordia, Carla Campos, Luping Huang, et al.
CNS & Neurological Disorders Drug Targets|August 16, 2011
Targeting nicotinic receptors for Parkinson's disease therapyMaryka Quik, Tanuja Bordia, Luping Huang, et al.
Biochemical Pharmacology|June 21, 2015
Alpha7 nicotinic receptors as therapeutic targets for Parkinson's diseaseMaryka Quik, Danhui Zhang, Matthew McGregor, et al.
International Review of Neurobiology|October 17, 2015
Nicotine and Nicotinic Receptor Drugs: Potential for Parkinson's Disease and Drug-Induced Movement DisordersMaryka Quik, Tanuja Bordia, Danhui Zhang, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
The European Journal of Neuroscience|June 21, 2018
Cholinergic control of striatal neurons to modulate L-dopa-induced dyskinesiasTanuja Bordia, Xiomara A Perez
Frontiers in Systems Neuroscience|December 28, 2020
The Inferior Colliculus in Alcoholism and BeyondTanuja Bordia, Natalie M Zahr
Biochemical Pharmacology|July 17, 2007
Nicotinic receptors as CNS targets for Parkinson's diseaseMaryka Quik, Tanuja Bordia, Kathryn O'Leary
Journal of Neurochemistry|February 5, 2013
The nicotine-mediated decline in l-dopa-induced dyskinesias is associated with a decrease in striatal dopamine releaseTanuja Bordia, J Michael McIntosh, Maryka Quik
The Journal of Pharmacology and Experimental Therapeutics|December 7, 2011
Nicotine reduces antipsychotic-induced orofacial dyskinesia in ratsTanuja Bordia, J Michael McIntosh, Maryka Quik
Movement Disorders : Official Journal of the Movement Disorder Society|June 14, 2012
Nicotine as a potential neuroprotective agent for Parkinson's diseaseMaryka Quik, Xiomara A Perez, Tanuja Bordia
The Journal of Pharmacology and Experimental Therapeutics|July 25, 2008
Continuous and intermittent nicotine treatment reduces L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesias in a rat model of Parkinson's diseaseTanuja Bordia, Carla Campos, Luping Huang, et al.
CNS & Neurological Disorders Drug Targets|August 16, 2011
Targeting nicotinic receptors for Parkinson's disease therapyMaryka Quik, Tanuja Bordia, Luping Huang, et al.
Biochemical Pharmacology|June 21, 2015
Alpha7 nicotinic receptors as therapeutic targets for Parkinson's diseaseMaryka Quik, Danhui Zhang, Matthew McGregor, et al.
International Review of Neurobiology|October 17, 2015
Nicotine and Nicotinic Receptor Drugs: Potential for Parkinson's Disease and Drug-Induced Movement DisordersMaryka Quik, Tanuja Bordia, Danhui Zhang, et al.
Pageof 4